Machine signal
Active cluster sell — 5 distinct insiders, $18.1M, window ends Aug 28, 2026.
Figures computed from official regulatory filings — .
Analysttarget 71 USD (+28%) · consensus 5/5 · 4 buy · 0 hold · 0 sell
Ownershipinsiders 4.87% · institutions 71% · short 7.5% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Eton Pharmaceuticals, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
29 buys69 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| MAIER PAUL Vtrack record | Sell | $2.1M | Unusual size | SEC |
| MAIER PAUL Vtrack record | Exercise | $189K | SEC |
| MAIER PAUL Vtrack record | Sell | $7.9K | SEC |
| MAIER PAUL Vtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MAIER PAUL Vtrack record | Sell | $811.9K | Unusual size | SEC |
| MAIER PAUL Vtrack record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MAIER PAUL Vtrack record | Exercise | $91.4K | SEC |
| Krempa David | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Krempa David | Sell | $1.6M | Unusual size | SEC |
| Krempa David | Exercise | $182.8K | Unusual size | SEC |
| BRYNJELSEN SEANtrack record | Sell | $2.8M | SEC |
| BRYNJELSEN SEANtrack record | Sell | $456.1K | SEC |
| BRYNJELSEN SEANtrack record | Sell | $562.5K | SEC |
| BRYNJELSEN SEANtrack record | Sell | $2.2M | SEC |
| MAIER PAUL Vtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| RIEDEL NORBERT Gtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CASAMENTO CHARLES Jtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Krempa David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BRYNJELSEN SEANtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Adams Jennifer McKie | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Matthews Judith M. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Erdogan-Trinkaus Ipek | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Opaleye Management Inc.track record | Sell | $563.1K | SEC |
| Opaleye Management Inc.track record | Sell | $499.9K | SEC |
| BRYNJELSEN SEANtrack record | Exercise | n/a (No price was disclosed in the filing) | SEC |